RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
REGENTIS BIOMATERIALS LTD.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026
$1.48−0.01 (-0.67%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Regentis Biomaterials statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Orthopedic, Prosthetic & Surgical Appliances & Supplies companies for comparison
Valuation
| Measure | Regentis Biomaterials | Industry median |
|---|---|---|
| Market Cap | $7.67M | $230.55M |
| Enterprise Value | $7.67M | $202.97M |
| PB Ratio | 1.00 | 3.04 |
| P/TBV Ratio | 1.00 | 4.43 |
Income (trailing twelve months)
| Measure | Regentis Biomaterials | Industry median |
|---|---|---|
| Operating Income | -$6.97M | -$4.31M |
| Pretax Income | $13.65M | -$2.37M |
| Net Income | -$13.65M | -$6.57M |
| EBITDA | -$6.97M | -$1.98M |
| EPS (Diluted) | -$24.16 | -$0.08 |
Returns
| Measure | Regentis Biomaterials | Industry median |
|---|---|---|
| Return on Assets (ROA) | -146.0% | -13.3% |
| Return on Capital Employed (ROCE) | -90.5% | -9.07% |
Growth
| Measure | Regentis Biomaterials | Industry median |
|---|---|---|
| Net Income Growth (YoY) | -384.3% | 10.5% |
| EPS Growth (YoY) | -1504.7% | 10.6% |
Balance sheet
| Measure | Regentis Biomaterials | Industry median |
|---|---|---|
| Equity (Book Value) | $7.68M | $55.33M |
| Book Value Per Share | $1.48 | $2.87 |
| Tangible Book Value | $7.68M | $10.79M |
| Working Capital | $7.64M | $56.72M |
Financial position
| Measure | Regentis Biomaterials | Industry median |
|---|---|---|
| Current Ratio | 5.62 | 2.48 |
| Interest Coverage | -88.20 | -1.85 |
Cash flow (trailing twelve months)
| Measure | Regentis Biomaterials | Industry median |
|---|---|---|
| Operating Cash Flow | -$1.38M | -$566.22K |
Efficiency
| Measure | Regentis Biomaterials | Industry median |
|---|---|---|
| Profits Per Employee | -$4.55M | -$51.88K |
| Employee Count | 3 | 185 |
Dividends and yields
| Measure | Regentis Biomaterials | Industry median |
|---|---|---|
| Earnings Yield | -178.0% | -6.88% |
Shares
| Measure | Regentis Biomaterials | Industry median |
|---|---|---|
| Shares Outstanding | 5,179,380 | 44,302,700 |
| Shares Change (YoY) | -79.5% | 3.36% |
| Float | 3,447,370 | 37,462,700 |
| Shares Held by Insiders | 33.4% | 10.5% |
Scores
| Measure | Regentis Biomaterials | Industry median |
|---|---|---|
| Altman Z-Score | -7.47 | 1.95 |
Calculated by StockData from Regentis Biomaterials's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.